• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    M8, signs an exclusive agreement with SERB to bring Voraxaze to Latin America

    20 Mar 2024 //

    PR NEWSWIRE

    NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase

    07 Jul 2023 //

    ONCLIVE

    SERB SAS` Voraxaze (glucarpidase) Receives Approval in Europe

    20 Jan 2022 //

    EMA

    SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

    25 Nov 2021 //

    PRESS RELEASE

    Initial study results show feasibility of outpatient methotrexate administration

    12 Nov 2020 //

    PRNEWSWIRE

    BTG Specialty Pharmaceuticals announces the European Medicines Agency

    17 Aug 2020 //

    PRNEWSWIRE

    Study Underway to Examine the Planned Use of Voraxaze®

    23 Apr 2020 //

    PR NEWSWIR

    BTG International`s Voraxaze (Glucarpidase) Receives Supplemental Approval in US

    16 Aug 2019 //

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.